Contact – +1-276-477-5910
 Email – [email protected]

Home >> Reports

 Reports

North America Social Robots Market 2021-2031 by Component (Hardware, Software, Services), Technology (ML, NLP, Computer Vision, Context Awareness, Others), Industry Vertical (Healthcare, Education, Media and Entertainment, Retail, BFSI, Others), and Country: Trend Forecast and Growth Opportunity

North America social robots market is projected to grow by 21.4% annually in the forecast period and reach $4,069.4 million by 2031, driven by the increasing requirement for automation and digitalization, the significant adoption of robots in the healthcare industry and public services, rapid technological advancements in artificial intelligence (AI), and the growing R&D investment including government supporting initiatives. Highlighted with 21 tables and 38 figures, this 104-page report “North...

 9/30/2022 |  Artificial Intelligence |  Grace Market Data

Global Social Robots Market 2021-2031 by Component (Hardware, Software, Services), Technology (ML, NLP, Computer Vision, Context Awareness, Others), Industry Vertical (Healthcare, Education, Media and Entertainment, Retail, BFSI, Others), and Region: Trend Forecast and Growth Opportunity

Global social robots market will reach $10,998.3 million by 2031, growing by 21.8% annually over 2021-2031, driven by the increasing requirement for automation and digitalization, the significant adoption of robots in the healthcare industry and public services, rapid technological advancements in artificial intelligence (AI), and the growing R&D investment including government supporting initiatives. Highlighted with 80 tables and 74 figures, this 165-page report “Global Social Robots Market 20...

 9/30/2022 |  Artificial Intelligence |  Grace Market Data

Europe Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality (Adverse Event Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated), Clinical Phase (Pre-clinical, Phase I-IV), Method, Delivery Mode (On-premise, On-demand), Indication, End User (Pharma and Biotech Companies, CROs, BPOs, Others), and Country: Trend Forecast and Growth Opportunity

Europe pharmacovigilance and drug safety software market was valued at $61.1 million in 2021 and will grow by 7.4% annually over 2021-2031, driven by the increasing prevalence of chronic diseases due to the aging population, the growing drug discovery pipelines, increase in incidence of adverse drug reactions (ADR), more stringent regulatory guidelines for drug safety, and the increasing adoption of AI and cloud technologies in PV software and solutions. Highlighted with 33 tables and 60 fig...

 2022-10-04 |  Healthcare and Social Assistance |  Grace Market Data

North America Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality (Adverse Event Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated), Clinical Phase (Pre-clinical, Phase I-IV), Method, Delivery Mode (On-premise, On-demand), Indication, End User (Pharma and Biotech Companies, CROs, BPOs, Others), and Country: Trend Forecast and Growth Opportunity

North America pharmacovigilance and drug safety software market is projected to grow by 6.7% annually in the forecast period and reach $158.6 million by 2031, driven by the increasing prevalence of chronic diseases due to the aging population, the growing drug discovery pipelines, increase in incidence of adverse drug reactions (ADR), more stringent regulatory guidelines for drug safety, and the increasing adoption of AI and cloud technologies in PV software and solutions. Highlighted with 23 t...

 44773 |  Healthcare and Social Assistance |  Grace Market Data

Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market 2021-2031 by Service Type (Bioanalytical Testing, Method Development and Validation, Stability Testing, Others), Product Type (Raw Materials & Additives, APIs, Finished Products), End User (Pharma & Biopharma Companies, CMOs, Others), Organization Size (SMEs, Large Enterprises), and Country: Trend Forecast and Growth Opportunity

Asia Pacific pharmaceutical analytical testing outsourcing market will grow by 10.2% annually with a total addressable market cap of $30,233.3 million over 2022-2031, driven by the increasing pipelines for drug candidates, rising demand for additional analytical details on drugs as well as process development by regulatory agencies, entry of new contract organizations, and the lack of in-house equipment along with the rising adoption of outsourcing activities. Highlighted with 31 tables and 50 ...

 44773 |  Healthcare and Social Assistance |  Grace Market Data

Europe Pharmaceutical Analytical Testing Outsourcing Market 2021-2031 by Service Type (Bioanalytical Testing, Method Development and Validation, Stability Testing, Others), Product Type (Raw Materials & Additives, APIs, Finished Products), End User (Pharma & Biopharma Companies, CMOs, Others), Organization Size (SMEs, Large Enterprises), and Country: Trend Forecast and Growth Opportunity

Europe pharmaceutical analytical testing outsourcing market was valued at $1,919.1 million in 2021 and will grow by 8.4% annually over 2021-2031, driven by the increasing pipelines for drug candidates, rising demand for additional analytical details on drugs as well as process development by regulatory agencies, entry of new contract organizations, and the lack of in-house equipment along with the rising adoption of outsourcing activities. Highlighted with 34 tables and 51 figures, this 109-pag...

 44773 |  Healthcare and Social Assistance |  Grace Market Data

North America Pharmaceutical Analytical Testing Outsourcing Market 2021-2031 by Service Type (Bioanalytical Testing, Method Development and Validation, Stability Testing, Others), Product Type (Raw Materials & Additives, APIs, Finished Products), End User (Pharma & Biopharma Companies, CMOs, Others), Organization Size (SMEs, Large Enterprises), and Country: Trend Forecast and Growth Opportunity

North America pharmaceutical analytical testing outsourcing market is projected to grow by 7.5% annually in the forecast period and reach $ 6,029.2 million by 2031, driven by the increasing pipelines for drug candidates, rising demand for additional analytical details on drugs as well as process development by regulatory agencies, entry of new contract organizations, and the lack of in-house equipment along with the rising adoption of outsourcing activities. Highlighted with 24 tables and 47 fi...

 44773 |  Healthcare and Social Assistance |  Grace Market Data

Asia Pacific Personal Mobility Devices Market 2021-2031 by Product (Wheelchairs, Walking Aids, Scooters, Others), End User (Hospitals and Clinics, Homecare Settings, ASCs, Urgent Care Centers, Others), and Country: Trend Forecast and Growth Opportunity

Asia Pacific personal mobility devices market will grow by 8.4% annually with a total addressable market cap of $38,844.0 million over 2022-2031, driven by the aging population and surge in chronic diseases, increasing disability cases and accidents causing impairment of the limbs, increasing product development, rising purchasing power, and the favorable reimbursement policies. Highlighted with 23 tables and 37 figures, this 90-page report “Asia Pacific Personal Mobility Devices Market 2021-20...

 44773 |  Healthcare and Social Assistance |  Grace Market Data

Europe Personal Mobility Devices Market 2021-2031 by Product (Wheelchairs, Walking Aids, Scooters, Others), End User (Hospitals and Clinics, Homecare Settings, ASCs, Urgent Care Centers, Others), and Country: Trend Forecast and Growth Opportunity

Europe personal mobility devices market was valued at $3,519.5 million in 2021 and will grow by 6.1% annually over 2021-2031, driven by the aging population and surge in chronic diseases, increasing disability cases and accidents causing impairment of the limbs, increasing product development, rising purchasing power, and the favorable reimbursement policies. Highlighted with 25 tables and 38 figures, this 90-page report “Europe Personal Mobility Devices Market 2021-2031 by Product (Wheelchairs...

 44773 |  Healthcare and Social Assistance |  Grace Market Data

North America Personal Mobility Devices Market 2021-2031 by Product (Wheelchairs, Walking Aids, Scooters, Others), End User (Hospitals and Clinics, Homecare Settings, ASCs, Urgent Care Centers, Others), and Country: Trend Forecast and Growth Opportunity

North America personal mobility devices market is projected to grow by 5.8% annually in the forecast period and reach $7,046.9 million by 2031, driven by the aging population and surge in chronic diseases, increasing disability cases and accidents causing impairment of the limbs, increasing product development, rising purchasing power, and the favorable reimbursement policies. Highlighted with 18 tables and 34 figures, this 84-page report “North America Personal Mobility Devices Market 2021-203...

 44773 |  Healthcare and Social Assistance |  Grace Market Data

x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT